4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-24-119051
10% owner sold 157,895 shares at an average $9.44 ($1,491,041)
- 10% owner disposed of 1,435,402 shares (other)
- 10% owner acquired 48,945 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Versant Venture Capital VI, L.P. · 10% owner
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-28 | Sale : show line 1 in the form | −89,990 | $9.66 | $869,240 | 2,007,948 | I |
| 2024-10-28 | Other disposition : show line 2 in the form | −1,019,867 | 4,079,469 | D | ||
| 2024-10-28 | Other acquisition : show line 3 in the form | +20,397 | 20,397 | I | ||
| 2024-10-28 | Other disposition : show line 4 in the form | −20,397 | 0 | I | ||
| 2024-10-28 | Other acquisition : show line 5 in the form | +17,595 | 17,595 | I | ||
| 2024-10-28 | Other disposition : show line 6 in the form | −17,595 | 0 | I | ||
| 2024-10-28 | Other disposition : show line 7 in the form | −366,590 | 1,641,358 | I | ||
| 2024-10-28 | Other acquisition : show line 8 in the form | +5,499 | 5,499 | I | ||
| Open-market sales · 157,895 sh · avg $9.44 · $1,491,041 | ||||||
Loading xslF345X05/ownership.xml…